WHO Worldwide country situation analysis:

response to antimicrobial resistance


President's 2016 Budget Proposes Historic Investment to Combat Antibiotic-Resistant Bacteria to Protect Public Health

"We now have a national strategy to combat antibiotic-resistant bacteria, to better protect our children and grandchildren from the reemergence of diseases and infections that the world conquered decades ago" - President Barack Obama at the Global Health Security Agenda Summit, September 26, 2014 

The $1.2 billion investment nearly doubles the current spending and aims to improve antibiotic stewardship; strengthen antibiotic resistance risk assessmentm surveillance, and reporting capabilities; and foster research innovation in the human health and agricultural sectors.

APUA has written to the White House to commend the Obama administration for it's prudent response to the global problem of antibiotic resistance. 

Read the full Fact Sheet here.


Antibiotics are humanity's key defense against disease-causing microbes. The growing prevalence of antibiotic resistance threatens a future where these drugs can no longer cure infections and killer epidemics run rampant. The Alliance for the Prudent Use of Antibiotics (APUA) has been the leading global non-governmental organization fighting to preserve the effectiveness of antimicrobial drugs since 1981. With affiliated chapters in over 66 developed and developing countries, we conduct research, education and advocacy programs to control antimicrobial resistance and ensure access to effective antibiotics for current and future generations. For more information on antibiotic resistance research, visit our partner lab at the Center for Adaptation Genetics and Drug Resistance.

Antibiotic Resistance
in the News

The National Action Plan for Combating Antibiotic-Resistant Bacteria, 2015

2014 PCAST Report on 
Combating Antimicrobial Resistance

The 2014 WHO Report on
Antimicrobial Resistance:

The 2013 CDC Report:





Public Health AdvocacyGlobal Research and Survellience

Consumer and Practioner ResourcesAPUA Chapters

"Antibiotics are uniquely societal drugs because individual use affects others in the community and environment.  Better stewardship, incentives, and establishment of a special regulatory category will improve how they are used, marketed, and developed through incentives to industry."

Stuart B. Levy, M.D.
President of APUA, professor at Tufts University School of Medicine

From the IOM 25th Anniversary Symposium (1996) and The Antibiotic Paradox (2002)

2014 Alliance for the Prudent Use of Antibiotics | 136 Harrison Ave, M&V Suite 811, Boston, MA, 02111 | Tel 617.636.0966 | apua@tufts.eduHome | Search | Contact Us